Cumulative incidence rates of the mucopolysaccharidoses in Germany

Journal of Inherited Metabolic Disease

Volumn 28, Issue 6, 2005, Pages 1011-1017

  Baehner, F ^a   Schmiedeskamp, C ^a   Krummenauer, F ^b   Miebach, E ^a   Bajbouj, M ^a   Whybra, C ^a   Kohlschutter A ^c   Kampmann, C ^a   Beck, M ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; GERMANY; GLOBOID CELL LEUKODYSTROPHY; HEALTH SURVEY; HUMAN; HUNTER SYNDROME; HURLER SYNDROME; INCIDENCE; INDUSTRIALIZATION; MAJOR CLINICAL STUDY; MAROTEAUX LAMY SYNDROME; MORBIDITY; MORQUIO SYNDROME; MUCOPOLYSACCHARIDOSIS; MUCOPOLYSACCHARIDOSIS TYPE 7; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; RETROSPECTIVE STUDY; SANFILIPPO SYNDROME; SCHEIE SYNDROME; SEX RATIO; TURKEY (REPUBLIC);

BETA-GALACTOSIDASE; FEMALE; GENOTYPE; GERMANY; HOSPITAL RECORDS; HUMANS; INCIDENCE; MALE; MUCOPOLYSACCHARIDOSES; PHENOTYPE; RETROSPECTIVE STUDIES; TURKEY;

EID: 31644446680     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-005-0112-z     Document Type: Article

References (24)

1. Applegarth DA, Toone JR, Lowry RB (2000) Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 105: E10.
2. Breslow N, Day N (1987) The design and analysis of cohort studies. In: Statistical Methods in Cancer Research, vol. II. Lyon: IARC Publications.
3. Bunge S, Kleijer WJ, Steglich C, et al (1994) Mucopolysaccharidosis type I: Identification of 8 novel mutations and determination of the frequency of the two common alpha- L -iduronidase mutations (W402X and Q70X) among European patients. Hum Mol Genet 3: 861-866.
4. Bunge S, Kleijer WJ, Steglich C, Beck M, Schwinger E, Gal A (1995) Mucopolysaccharidosis type I: Identification of 13 novel mutations of the alpha- L -iduronidase gene. Hum Mutat 6: 91-94.
5. Coelho JC, Wajner M, Burin MG, Vargas CR, Giugliani R (1997) Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism. Eur J Pediatr 156: 650-654.
6. Cornel MC (1999) Common language for measures of occurrence of congenital anomalies and genetic diseases: Incidence or birth prevalence. Community Genet 2: 162-164.
7. Desnick RJ (2004) Enzyme replacement and enhancement therapies for lysosomal diseases. J Inherit Metab Dis 27: 385-410.
8. Diamond JM (1994) Human genetics. Jewish lysosomes. Nature 368: 291-292.
9. Emre S, Terzioglu M, Coskun T, et al (2002) Biochemical and molecular analysis of mucopolysaccharidoses in Turkey. Turk J Pediatr 44: 13-17.
10. Lowry RB, Renwick DH (1971) Relative frequency of the Hurler and Hunter syndromes. N Engl J Med 284: 221-222.
11. Lowry RB, Applegarth DA, Toone JR, MacDonald E, Thunem NY (1990) An update on the frequency of mucopolysaccharide syndromes in British Columbia. Hum Genet 85: 389-390.
12. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281: 249-254.
13. Michelakakis H, Dimitriou E, Tsagaraki S, Giouroukos S, Schulpis K, Bartsocas CS (1995) Lysosomal storage diseases in Greece. Genet Couns 6: 43-47.
14. Nelson J (1997) Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 101: 355-358.
15. Nelson J, Crowhurst J, Carey B, Greed L (2003) Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet 123A: 310-313.
16. Poorthuis BJ, Wevers RA, Kleijer WJ et al (1999) The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 105: 151-156.
17. Poupetova H (2003) Prevalence of lysosomal storage disorders in the Czech and Slovak Republics. ESGLD Workshop, Podebrady, Czech Republic. Sponsoring Organization: European Study Group on Lysosomal Diseases.
18. Schaap T, Bach G (1980) Incidence of mucopolysaccharidoses in Israel: Is Hunter disease a "Jewish disease"? Hum Genet 56: 221-223.
19. Triggs-Raine B, Salo TJ, Zhang H, Wicklow BA, Natowicz MR (1999) Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX. Proc Natl Acad Sci USA 96 6296-6300.
20. Van de Kamp JJP (1979) The Sanfilippo syndrome: A clinical and genetical study of 75 patients in The Netherlands. Thesis: University of Leiden.
21. Vervoort R, Islam MR, Sly WS, et al (1996) Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. Am J Hum Genet 58: 457-471.
22. Vervoort R, Gitzelmann R, Bosshard N, Maire I, Liebaers I, Lissens W (1998) Low beta-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote. Hum Genet 102: 69-78.
23. Weber B, Guo XH, Kleijer WJ, van de Kamp JJ, Poorthuis BJ, Hopwood JJ (1999) Sanfilippo type B syndrome (mucopolysaccharidosis III B): Allelic heterogeneity corresponds to the wide spectrum of clinical phenotypes. Eur J Hum Genet 7: 34-44.
24. Yogalingam G, Hopwood JJ (2001) Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications. Hum Mutat 18: 264-281.